Share

March 14, 2021 The Irish health authorities have asked for the temporary and precautionary suspension of the use of the anti-Covid vaccine developed by AstraZeneca, a measure already adopted by several other European countries due to fears of serum side effects.



"This recommendation was made following a report from the Norwegian Medicines Agency on four new reports of serious blood clotting events in adults after vaccination with AstraZeneca's Covid-19 vaccine," said the Deputy Chief Medical Officer of Ireland, Ronan Glynn, quoted by local media.



Glynn specified that "no link" between the vaccine in these cases has yet been established.

"However, acting on the precautionary principle and pending further information, the National Immunization Advisory Committee recommended the temporary postponement of the vaccination program with AstraZeneca in Ireland," he added. 



Reasons for the precautionary suspension in Norway


The Norwegian health authorities have expressed concern over cases of skin bleeding in relatively young people who have received a dose of the AstraZeneca vaccine against Covid-19.

although no definite link with the vaccine has yet been established, "this is serious and could be a sign of a decrease in the number of platelets," warned the Norwegian Institute of Public Health, which had already discontinued the vaccine "for precaution "because of concerns about blood clots.



The institute now invites people under 50 who show symptoms more than three days after vaccination to see a doctor.

Additionally, three health care workers were recently admitted to Oslo University Hospital with blood clots after receiving the AstraZeneca vaccine.

One death occurred as a result of a brain haemorrhage.

Again, the country's health authorities have not yet established a link with the administration of the AstraZeneca vaccine but are investigating the case. 



The inspectors of the Ministry of Health today in Sicily


Officials will carry out checks on the death of Stefano Paternò, the 43-year-old non-commissioned officer of the Navy who died in Misterbianco (Ct) the day after receiving a dose of AstraZeneca vaccine.



The Catania prosecutor investigates


An

investigation 

was opened by the Catania prosecutor's office on possible contraindications of the AstraZeneca vaccine against Covid 19 on thrombophilic subjects.

the investigation, against unknown persons, assumes the crime envisaged by article 443 of the criminal code: "trade or administration of broken or imperfect medicines".

The newspaper la Repubblica writes it.

"We are verifying - says the prosecutor Carmelo Zuccaro - whether certain thrombophilic subjects may have a predisposition to activate certain detonating factors. There may be contraindications in the vaccine for some people, contraindications that have not been analyzed considering the limited time available for the realization of the drug".



Information has already been requested from the prosecutors investigating some deaths.



Yesterday, the prosecutor of Gela also seized the medical records of a 37-year-old teacher who is in very serious condition due to a cerebral hemorrhage and who had received the vaccine on March 1 (a different batch from the one withdrawn by AIFA).



Another case investigated by the prosecutor, which however did not cause the death of the vaccinated subject, was registered in Catania.



Also in Catania yesterday, in addition to the autopsy on the body of Stefano Paternò, the non-commissioned officer of the Navy who died last Monday 15 hours after undergoing the first dose of the vaccine, tests were carried out on the blood and on some organs taken (liver and spleen) from the body of Davide Villa, the policeman who died on March 6, sixteen days after the vaccine.



The specialists had the task of looking for the "genetic predisposition for hereditary thrombophilia (factor v leiden), factor ii mutated, mutations on the MTHFR gene (variants C677T and A1298C)".



EU, Breton: new "unacceptable" cuts, but Pfizer, increases production


The planned new cuts in supplies of coronavirus vaccines announced by AstraZeneca are "unacceptable or, at least, incomprehensible" but they do not change the vaccination plans of the European Union, also because Pfizer, on the other hand, is producing more serum than expected.

This was stated by the European Commissioner for the Internal Market, Thierry Breton, in an interview with radio Europe 1. "When you sign a contract that goes far beyond the commercial dimension, given the importance of the products, if there are inconsistencies, it is up to me to report them and to the board of directors to take the necessary measures, "said Breton.

"67 million doses have been distributed in Europe and in three weeks we will have more than 100 million, an unprecedented rate", added the EU commissioner.